NRAS and Friedreich ataxia: Importantly, potentially targetable mutations, including the AKT1 E17K, ERBB2 V777L, ERBB3 V104L, NRAS Q61K, and PIK3CA H1047R hotspot mutations, were restricted to PTs without FA-like areas (Fig. 2).